Literature DB >> 15326209

Characterization of Fxr1 in Danio rerio; a simple vertebrate model to study costamere development.

Bart Engels1, Sandra van 't Padje, Lau Blonden, Lies-Anne Severijnen, Ben A Oostra, Rob Willemsen.   

Abstract

The X-linked FMR1 gene, which is involved in the fragile X syndrome, forms a small gene family with its two autosomal homologs, FXR1 and FXR2. Mouse models for the FXR genes have been generated and proved to be valuable in elucidating the function of these genes, particularly in adult mice. Unfortunately, Fxr1 knockout mice die shortly after birth, necessitating an animal model that allows the study of the role of Fxr1p, the gene product of Fxr1, in early embryonic development. For gene function studies during early embryonic development the use of zebrafish as a model organism is highly advantageous. In this paper the suitability of the zebrafish as a model organism to study Fxr1p function during early development is explored. As a first step, we present here the initial characterization of Fxr1p in zebrafish. Fxr1p is present in all the cells from zebrafish embryos from the 2/4-cell stage onward; however, during late development a more tissue-specific distribution is found, with the highest expression in developing muscle. In adult zebrafish, Fxr1p is localized at the myoseptum and in costamere-like granules in skeletal muscle. In the testis, Fxr1p is localized in immature spermatogenic cells and in brain tissue Fxr1p displays a predominantly nuclear staining in neurons throughout the brain. Finally, the different tissue-specific isoforms of Fxr1p are characterized. Since the functional domains and the expression pattern of Fxr1p in zebrafish are comparable to those in higher vertebrates such as mouse and human, we conclude that the zebrafish is a highly suitable model for functional studies of Fxr1p.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15326209     DOI: 10.1242/jeb.01146

Source DB:  PubMed          Journal:  J Exp Biol        ISSN: 0022-0949            Impact factor:   3.312


  8 in total

1.  FXR1 is elevated in colorectal cancer and acts as an oncogene.

Authors:  Xin Jin; Bo Zhai; Taishi Fang; Xiaohui Guo; Lishan Xu
Journal:  Tumour Biol       Date:  2015-09-24

2.  Characterisation of Fmrp in zebrafish: evolutionary dynamics of the fmr1 gene.

Authors:  Sandra van 't Padje; Bart Engels; Lau Blonden; Lies-Anne Severijnen; Frans Verheijen; Ben A Oostra; Rob Willemsen
Journal:  Dev Genes Evol       Date:  2005-01-27       Impact factor: 0.900

Review 3.  Nervous translation, do you get the message? A review of mRNPs, mRNA-protein interactions and translational control within cells of the nervous system.

Authors:  Ross Smith; Reena Jagdish Rathod; Shalini Rajkumar; Derek Kennedy
Journal:  Cell Mol Life Sci       Date:  2014-06-22       Impact factor: 9.261

4.  The RNA-binding protein fragile X-related 1 regulates somite formation in Xenopus laevis.

Authors:  Marc-Etienne Huot; Nicolas Bisson; Laetitia Davidovic; Rachid Mazroui; Yves Labelle; Tom Moss; Edouard W Khandjian
Journal:  Mol Biol Cell       Date:  2005-07-06       Impact factor: 4.138

5.  Desmoplakin and talin2 are novel mRNA targets of fragile X-related protein-1 in cardiac muscle.

Authors:  Samantha A Whitman; Cathleen Cover; Lily Yu; David L Nelson; Daniela C Zarnescu; Carol C Gregorio
Journal:  Circ Res       Date:  2011-06-09       Impact factor: 17.367

Review 6.  Concise review: Fragile X proteins in stem cell maintenance and differentiation.

Authors:  Yue Li; Xinyu Zhao
Journal:  Stem Cells       Date:  2014-07       Impact factor: 6.277

Review 7.  RNA binding proteins in the regulation of heart development.

Authors:  Yotam Blech-Hermoni; Andrea N Ladd
Journal:  Int J Biochem Cell Biol       Date:  2013-08-20       Impact factor: 5.085

8.  Bcl-2-associated transcription factor 1 interacts with fragile X-related protein 1.

Authors:  Yun Ma; Changbo Wang; Binyuan Li; Lingxue Qin; Jiao Su; Manjun Yang; Shuya He
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2014-01-03       Impact factor: 3.848

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.